This event will be rescheduled for a day during this Fall.
April 21, 2020
8 am – 4:30 pm
Hilton Garden Inn, Stony Brook, NY
To showcase the long tradition at Stony Brook University of excellence in basic biological mechanisms of cancer, this year’s symposium will highlight research aimed at understanding and exploiting the critical and common genetic driver events in human cancers.
Session 1. P53, The Ultimate Molecular Chameleon
Session 2 The Challenges and Opportunities in Undruggable KRAS
This year we are very pleased to announce that we will be joined at this exciting and educational symposium by two internationally recognized keynote speakers and leaders in the p53 and KRAS fields:
Guillermina (‘Gigi’) Lozano, PhD
Professor of Genetics at the MD Anderson Cancer Center who is recognized for her studies of the p53 tumor suppressor pathway, from characterizing p53 as a transcriptional activator to characterizing the physiological importance of Mdm2 and Mdm4 proteins as inhibitors.
Channing Der, PhD
The Sarah Graham Kenan Distinguished Professor of Pharmacology at the University of North Carolina and member of the UNC Lineberger Comprehensive Cancer Center who was recently named a Fellow of the American Association for the Advancement of Science (AAAS) for his role in the discovery of mutant KRAS in 1982 and his contributions to the understanding how mutant KRAS, commonly mutated in pancreatic cancer, promotes the development of cancer and acts as a target for new drug development.
|8 – 8:45 am||Breakfast and Registration|
|8:45 – 9 am||Welcome|
|9 – 10:20 am||Session 1|
|10:20 - 10:35 am||Coffee Break|
|10:35 -11:35 am||Talks/Short Talks|
|11:35 am - Noon||Group Photo|
|Noon - 1 pm||Lunch|
|1- 2 pm||Poster Session|
|2- 3:40 pm||Session 2|
|3:40 - 3:55 pm||Coffee Break|
|4 - 4:20 pm||Talks|
|4:20 - 4:30 pm||Poster Awards and Closing Remarks|
*Please note, space is limited and registration is required to attend this event.
Registration closes on April 15.